About Applied BiologyApplied Biology, headquartered in Irvine, California, is a biopharmaceutical company paving the way to radically new therapies in dermatology. Our research spans novel compounds ushering a paradigm shift in phototherapy to transformation of microbial organisms to deliver dermatological therapy.
Founded by industry luminaries Prof. Andy Goren, Prof Torello Lotti, and Daniel Hafid in collaboration with world renowned dermatologists Dr. Jerry Shapiro, Dr. Jana Hercogova, and Dr. Robert Schwartz, Applied Biology is poised to brighten the future of dermatology patients.
Founders: Andy Goren, Prof Torello Lotti, and Daniel Hafid
Please click here for clinical trial information.
9 articles with Applied Biology
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for September 23, 2020.
Applied Biology and Corpometria Institute Receive National IRB Approval to Study a Potential Breakthrough Therapy for COVID-19
While studying the genetics of the androgen receptor, a team of scientists discovered a possible breakthrough treatment for COVID-19. The team led by Andy Goren, MD from Applied Biology, Flavio A. Cadegiani, MD, MSc, PhD from Corpometria Institute in Brazil, along with other collaborators, have published their discovery in several medical journ
While studying the effects of androgens on hair loss, Applied Biology scientists discovered an association between cellular receptors that predispose an individual to develop common hair loss (androgenetic alopecia) and COVID-19.
Applied Biology, in Collaboration With Brown University Researchers and Corpometria Institute, to Launch Anti-Androgen Clinical Study for the Treatment of COVID-19 (ANDROCOV TRIAL)
While studying the genetics of the androgen receptor in male pattern baldness, a team of scientists discovered a possible breakthrough treatment for COVID-19.
Applied Biology to License Intellectual Property Rights to a Novel Cannabinoid Based Therapy Under Development for COVID-19
Applied Biology, Inc. ("Applied Biology") announced today it has licensed to Applied Botanics, LLC. (Louisville, KY) intellectual property rights to a novel cannabinoid based therapy under development for COVID-19 and other respiratory illnesses.
APPLIED BIOLOGY TO INAUGURATE A NEW CLINICAL LABORATORY IN A BID TO PROVIDE DOCTORS AND PATIENTS WITH ACCESS TO BREAKTHROUGH RESEARCH IN HAIR AND SKIN SCIENCE
Applied Biology to Enter into a License Agreement with Hairmore for its Novel Treatment for Traction Alopecia
Applied Biology's Novel Taar Receptor Agonist To Help Millions Of Chinese Women Suffering From Ponytail Induced Alopecia
APPLIED BIOLOGY TO EXPAND ITS LEADERSHIP TEAM IN A BID TO COMMERCIALIZE ITS INNOVATIVE AESTHETICS PRODUCT PIPELINE